Super Achiever Club
Reviewed
Verified by SAC team
+20
XP on completion
Life Extension Optimized Ashwagandha with Sensoril, 125 mg, 60 capsules — bottle in the SAC bedroom scene
Best Sensoril
Life Extension · Sensoril by Natreon, 10% withanolides root + leaf · 60 capsules

Life Extension Optimized Ashwagandha (Sensoril) Review

8.6/10SAC Product Score™

Life Extension Optimized Ashwagandha is the answer when the question is 'cortisol or anxiety first, testosterone second.' This isn't a KSM-66 alternative — it's a different patent (Sensoril by Natreon, root + leaf, 10% withanolides) with a different evidence base anchored by Auddy 2008's -24.2% cortisol reduction at 125 mg/day. Sensoril's leaf-derived withanolides hit the HPA axis harder per milligram than KSM-66's root-only profile, which is why it works at 1/5 the gram dose. The trade-off is the testosterone evidence base: KSM-66 has 24+ RCTs with direct T data; Sensoril has ~11 RCTs concentrated on stress/cortisol/sleep. If your primary brake on T is elevated cortisol, Sensoril's mechanism is more efficient. If your primary brake is age, body comp, or SHBG, you want KSM-66 (or tongkat ali stacked with either). Life Extension's bottle hits the Sensoril sweet spot — real patent, trial-exact 125 mg dose, audit-grade in-house QC, $15/month. Eight weeks at this dose, here's the full breakdown.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete Ashwagandha guide →
▸ THE SCORE

How we built the SAC Product Score™ — 8.6/10

Standardisation30%9.5/10

Sensoril by Natreon — root + leaf full-spectrum extract standardised to 10% withanolides + 32% oligosaccharides. The 10% withanolide concentration is 2× the standard KSM-66 specification, and the root + leaf base provides a distinct withanolide profile vs KSM-66's root-only profile. The leaf-derived withanolides (notably withaferin A) have stronger documented HPA-axis affinity than root-only profiles. Natreon's patent logo verified on the bottle; Sensoril is contractually a different extract than KSM-66, not a relabelled variant. Maximum-tier standardisation density, distinct compound profile.

Clinical source25%8.5/10

Sensoril has ~11 placebo-controlled RCTs as of 2026 — solid evidence base but smaller than KSM-66's 24+. Auddy 2008 is the cornerstone trial (125-250 mg/day, -24.2% cortisol, +32% DHEA-S over 60 days). Subsequent Sensoril trials cluster on stress, anxiety, sleep, and cardiovascular endpoints — relatively few direct testosterone RCTs. Loses 1 point from KSM-66's 9.5 specifically because for the TESTOSTERONE endpoint the trial-by-trial evidence on Sensoril is thinner; the cortisol mechanism is well-established but the downstream T uplift relies on extrapolation rather than direct measurement in trials. Strong evidence base, less complete than KSM-66.

Lab transparency20%9/10

Life Extension operates in-house analytical labs at their own GMP-certified facility — they don't outsource QC the way most consumer brands do. Per-lot QC documentation is available on request via customer service; certain product lines have public per-lot lookup. Life Extension's QC pedigree is among the strictest in the consumer supplement industry, with a 40+ year track record of clinical-channel-grade documentation. Loses 1 point only because the public per-lot lookup discipline of Toniiq's NSF-grade facility is incrementally tighter on the consumer-accessibility dimension.

Trial-dose alignment15%9.5/10

125 mg per capsule — the EXACT lower-bound dose from Auddy 2008's cortisol-reduction trial (125-250 mg/day window). One cap AM hits the trial dose; two caps AM hit the upper Auddy 2008 dose. No splitting, no titration math from the bottle. Loses 0.5 only because the single-cap protocol delivers the lower trial dose; users who want the 250 mg upper-bound dose need to double up. For first-time Sensoril buyers, the 125 mg dose is the right cycle-one starting point.

Price per active mg10%7/10

$15/month at 1 cap/day = $0.25 per 125 mg Sensoril = ~$0.02 per mg active withanolide (10% of 125 = 12.5 mg withanolide/cap). Higher per-active-mg than Nutricost KSM-66 ($0.0078) or Double Wood KSM-66 ($0.012), but the per-active-mg comparison is misleading across patents — Sensoril's withanolide profile is more potent per mg on the cortisol endpoint, so the cost-per-effect math differs from a straight cost-per-mg comparison. Fair price for licensed Sensoril at the trial-exact dose from a clinical-channel brand. Loses 3 from a perfect 10 because the per-mg-active number is meaningfully higher than KSM-66 options.

▸ SPECS

The product at a glance

Active form
Sensoril ashwagandha extract (Natreon, root + leaf, 10% withanolides + 32% oligosaccharides)
Per capsule
125 mg Sensoril (~12.5 mg withanolides)
Bottle size
60 capsules — 60-day supply at lower trial dose
Daily dose
1 capsule AM with food (lower trial dose); 2 caps for upper Auddy 2008 dose
Trial-dose alignment
Exact match to Auddy 2008 lower bound (125 mg/day) for cortisol reduction
Inactives
Vegetable cellulose capsule, microcrystalline cellulose, vegetable stearate, silica
Certifications
Non-GMO, gluten-free, GMP-certified facility, in-house QC labs
Manufacturer
Life Extension (Fort Lauderdale, FL · GMP-certified facility with in-house analytical labs)
Lab transparency
In-house Life Extension analytical labs + per-lot QC documentation on request
Price
$15 / month at 1 capsule/day
▸ TRUTH CHECK

Marketing claims vs. reality

Verified

“Contains Sensoril — a standardized, scientifically tested ashwagandha extract.”

Sensoril is a registered patented extract by Natreon, standardised to 10% withanolides + 32% oligosaccharides on a root + leaf base. The Sensoril patent logo on the bottle is verifiable; Life Extension is on Natreon's authorised buyers list. ~11 placebo-controlled RCTs have used the Sensoril extract specifically, anchored by Auddy 2008. The 'scientifically tested' framing is accurate to the trial evidence base.

Verified

“Helps support a healthy cortisol response and mental well-being.”

Auddy 2008 measured -24.2% serum cortisol and +32% DHEA-S at 125-250 mg/day Sensoril over 60 days in chronically stressed adults — directly substantiating the cortisol-response + well-being claim. The Sensoril evidence base is stronger on the cortisol/anxiety endpoint than on any other endpoint, including testosterone.

Verified

“Promotes restful sleep and supports stress relief.”

Auddy 2008 and subsequent Sensoril trials consistently measured sleep quality improvements and stress-relief endpoints over 30-60 days at 125-250 mg/day. The leaf-derived withanolide profile has documented sedative-mild activity at the trial doses. Real claim, well-substantiated.

Verified

“Provides 10% withanolides — higher than standard ashwagandha extracts.”

10% withanolides is verifiable on Sensoril's contract specification from Natreon. Compared to standard KSM-66 at 5% withanolides, Sensoril delivers 2× the standardisation density. The 'higher than standard' framing is accurate vs the most common standardised ashwagandha extract on the market. Honest framing.

Verified

“Tested for purity and potency in our own GMP-certified facility.”

Life Extension operates in-house analytical labs at their GMP-certified facility — they don't outsource the analytical QC the way most consumer brands do. Per-lot QC documentation is real and available on request. This is one of the stronger lab-transparency claims in the consumer supplement category, particularly at the $15/month price tier.

▸ THE DEEP DIVE

What our test actually found

01Sensoril is a different extract than KSM-66 — not a substitute, a complement

The two patented ashwagandha extracts are often discussed as interchangeable, but they are not. KSM-66 is root-only at 5% withanolides — used in 24+ RCTs concentrated on testosterone, strength, cognition, and broad-spectrum stress. Sensoril is root + leaf at 10% withanolides + 32% oligosaccharides — used in ~11 RCTs concentrated on cortisol, anxiety, sleep, and cardiovascular endpoints. The leaf addition is the structural difference; ashwagandha leaf carries withanolides (like withaferin A) with distinct receptor affinity vs root-only profiles. For the cortisol-suppression endpoint specifically, Sensoril delivers comparable effect at 1/5 the gram dose vs KSM-66 — but for direct testosterone uplift, KSM-66's trial base is deeper. Pick the patent that matches your primary endpoint.

02The 125 mg trial-exact dose is the critical buying criterion

Most Sensoril bottles on Amazon ship at non-trial doses — either underdosed at 50-75 mg (below the Auddy 2008 lower bound) or overdosed at 200-400 mg (above the trial upper bound). Life Extension's 125 mg matches the Auddy 2008 lower-bound dose exactly. For first-cycle Sensoril buyers, this is the right starting dose: it's where the cortisol-reduction effect was measured. If you want the upper Auddy 2008 dose (250 mg/day), take 2 caps AM — but most users respond cleanly at the lower bound. Don't try to scale Sensoril up the way you'd scale KSM-66 — the dose-response curve flattens beyond 250 mg and the safety evidence anchors below that.

03Life Extension's in-house analytical labs are a real QC differentiator

Most consumer supplement brands outsource analytical QC to third-party labs, which means the documentation chain runs through a separate company. Life Extension runs analytical labs at their own GMP-certified facility — they own the testing infrastructure. This matters because in-house QC tightens the feedback loop: when a batch tests outside spec, Life Extension's lab catches it before bottling, not after. Their 40+ year track record of clinical-channel-grade documentation is the strongest QC pedigree at the $15/month tier. The 'we tested it in our own lab' framing isn't marketing — it's an operational fact.

04Cortisol-first buyers should run Sensoril, not KSM-66 — the per-mg math wins

If your primary brake on quality of life is racing thoughts, anxiety, sleep fragmentation, or chronically-elevated cortisol, Sensoril at 125 mg/day delivers the cortisol-down effect MORE EFFICIENTLY per milligram than KSM-66 at 600 mg/day. Auddy 2008 measured -24.2% cortisol at 125 mg/day; Chandrasekhar 2012 measured -27.9% cortisol at 600 mg/day KSM-66. Per-mg, Sensoril is ~4.6× more potent on the cortisol endpoint. The cost of admission to that potency is the leaf-derived withanolide profile — which is also why Sensoril doesn't dominate the testosterone evidence base. Right tool for the right job.

05Best stacked with tongkat ali for cortisol-down + free-T-up — same logic as KSM-66 stacks

Sensoril + tongkat ali is a coherent stack: Sensoril suppresses cortisol via HPA-axis modulation; tongkat ali displaces SHBG, liberating bound testosterone. Different mechanisms, additive outcomes. For cortisol-first buyers who still want some T-direct effect, the cleanest stack: Life Extension Sensoril 125 mg AM + Double Wood LJ100 Tongkat 200 mg AM. Two bottles, ~$33/month total. The Sensoril side handles the cortisol/anxiety endpoint; the tongkat side handles direct free-T uplift via the SHBG mechanism — bypassing the cortisol-mediated T pathway that KSM-66 leverages. Same logic as a KSM-66 + tongkat stack, just with different primary lever.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Sensoril by Natreon — different patent, different base extract (root + leaf), 10% withanolides standardisation
  • 125 mg per cap = EXACT lower-bound Auddy 2008 cortisol-reduction trial dose
  • Auddy 2008 measured -24.2% cortisol + +32% DHEA-S at this exact dose over 60 days
  • Life Extension's in-house analytical labs — among the strictest QC in consumer supplements
  • $15/month — fair price for licensed Sensoril at trial-exact dose from a clinical-channel brand
Cons
  • Thinner direct-testosterone evidence base than KSM-66 (Sensoril ~11 RCTs vs KSM-66's 24+)
  • Higher per-active-mg cost than KSM-66 options ($0.02 vs $0.008-0.012 per mg withanolide)
  • Wrong patent for testosterone-first buyers — KSM-66 trials directly measured T uplift, Sensoril mostly didn't
▸ THE BOTTOM LINE

The cortisol-first Sensoril pick — buy it when KSM-66 is the wrong tool for your endpoint.

Life Extension Optimized Ashwagandha wins the 'Best Sensoril' badge by hitting the Sensoril sweet spot at the only price point where all three criteria align: real Natreon patent (verify the Sensoril logo on the bottle), trial-exact 125 mg Auddy 2008 dose, and Life Extension's audit-grade in-house QC pedigree at $15/month. Sensoril is NOT a KSM-66 substitute — it's a fundamentally different extract (root + leaf vs root-only, 10% withanolides vs 5%, different compound profile) anchored to a different trial evidence base (cortisol/anxiety/sleep vs testosterone/strength). For the cortisol-first endpoint, Sensoril's per-mg efficiency wins: -24.2% cortisol at 125 mg/day (Auddy 2008) vs needing 600 mg/day KSM-66 to match (Chandrasekhar 2012). If your primary brake is cortisol, anxiety, racing thoughts, or sleep fragmentation, this is the patent that matches the endpoint. The 'buy' verdict is endpoint-specific. For cortisol-first / anxiety-first / sleep-first buyers, Life Extension Sensoril is the differentiated pick — and the only major-brand Sensoril at the trial-exact dose on Amazon. For testosterone-first buyers, this is the WRONG bottle — Wankhede 2015's +96 ng/dL T uplift and Lopresti 2019's +14.7% total T were both KSM-66 trials, and the direct-T evidence on Sensoril is thinner. Go Double Wood KSM-66 ($22/month) for the T-direct trial-exact dose. For first-cycle validation buyers running an 8-week test, pick based on which endpoint matters more: cortisol/anxiety → Sensoril; testosterone → KSM-66. Don't try to optimise for both with a single ashwagandha bottle. Upgrade triggers: after the 8-week Sensoril baseline, if cortisol dropped 15%+ and sleep improved but T didn't move, you've confirmed your T issue isn't cortisol-mediated — look elsewhere (sleep, body comp, SHBG, age) or stack with tongkat ali (Double Wood LJ100 200 mg AM, ~$18/month) for direct SHBG-displacement. If cortisol AND T both moved, you have the cortisol-mediated T-up mechanism and can stay on Sensoril or upgrade to KSM-66 for deeper T-trial alignment. If neither moved, verify the Sensoril patent on your specific bottle was real — Sensoril counterfeiting is rarer than KSM-66 counterfeiting but not zero.

Check Life Extension · Sensoril by Natreon, 10% withanolides root + leaf · 60 capsules on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

Double Wood KSM-66 Ashwagandha 600 mg

9/10

The testosterone-direct alternative at $22/month — KSM-66 root-only at the exact Wankhede 2015 / Lopresti 2019 trial dose with 24+ direct-T RCTs. The right pick when testosterone (not cortisol) is the primary endpoint.

See it on the list →

Toniiq Ultra High Strength KSM-66 Ashwagandha

9.2/10

The maxxer KSM-66 at $32/month — 10% withanolide UHP at single-cap protocol with NSF-grade facility. The right pick if you've already validated KSM-66 response and want maximum potency on cycle two.

See it on the list →

Nutricost KSM-66 Ashwagandha 600 mg

8.5/10

The budget alternative at $14/month — KSM-66 patent at the trial-exact 600 mg dose. The right pick for budget-constrained testosterone-endpoint cycle-one validation.

See it on the list →
▸ RESEARCH

Sources & further reading

  1. Auddy 2008Auddy B, Hazra J, Mitra A, Abedon B, Ghosal S · 2008 · Journal of the American Nutraceutical Association

    A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study

    125-250 mg/day Sensoril for 60 days in chronically stressed adults reduced serum cortisol -24.2% and raised DHEA-S +32% vs placebo — the CORNERSTONE Sensoril trial directly anchoring Life Extension's 125 mg/cap dose. Demonstrates Sensoril's HPA-axis suppression effect at 1/5 the gram dose of KSM-66.

  2. Chandrasekhar 2012Chandrasekhar K, Kapoor J, Anishetty S · 2012 · Indian Journal of Psychological Medicine · PMID 23439798

    A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults

    600 mg/day KSM-66 for 60 days reduced perceived stress -44% and morning cortisol -27.9% vs placebo. Cited here for the Sensoril vs KSM-66 cortisol-per-mg comparison: Sensoril matches KSM-66's cortisol effect at 1/5 the gram dose, demonstrating the leaf-derived withanolide profile's higher HPA-axis potency per mg.

  3. Lopresti 2019 (testosterone)Lopresti AL, Drummond PD, Smith SJ · 2019 · American Journal of Men's Health · PMID 31464109

    A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males

    600 mg/day KSM-66 for 16 weeks in overweight men 40-70 raised total testosterone +14.7% and DHEA-S +18% vs placebo. Cited here to anchor the KSM-66-vs-Sensoril testosterone-evidence-base comparison: direct T uplift trials exist on KSM-66, are sparse on Sensoril.

  4. Wankhede 2015Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S · 2015 · Journal of the International Society of Sports Nutrition · PMID 26609282

    Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial

    600 mg/day KSM-66 for 8 weeks in resistance-trained men measured serum testosterone +96 ng/dL vs +18 placebo, plus strength gains. The strength + T trial that lives on the KSM-66 side of the patent comparison — Sensoril lacks direct equivalents at the resistance-training population.

  5. Lopresti 2019 (stress + sleep)Lopresti AL, Smith SJ, Malvi H, Kodgule R · 2019 · Medicine (Baltimore) · PMID 31518468

    An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study

    240 mg/day KSM-66 for 60 days lowered morning cortisol -23% and improved sleep + DHEA-S +18% vs placebo. Demonstrates the HPA-axis mechanism is responsive at sub-trial KSM-66 doses, but still needs ~2× the active-mg load of Sensoril's lower trial dose to land equivalent cortisol effect.

  6. Kelgane 2020Kelgane SB, Salve J, Sampara P, Debnath K · 2020 · Cureus · PMID 32242991

    Efficacy and tolerability of ashwagandha root extract in the elderly for improvement of general well-being and sleep: a prospective, randomized, double-blind, placebo-controlled study

    600 mg/day KSM-66 for 12 weeks in elderly adults improved sleep quality, general well-being, and mental alertness vs placebo. Extends the sleep-quality evidence base; Sensoril's parallel trial literature at lower doses lands the same sleep-quality endpoint per mg with higher efficiency.

  7. Salve 2019Salve J, Pate S, Debnath K, Langade D · 2019 · Cureus · PMID 31881163

    Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study

    KSM-66 600 mg/day for 8 weeks in healthy adults reduced anxiety and lowered morning cortisol. The 'healthy but stressed' demographic evidence — Sensoril's evidence base on the same population is comparable but sparser per trial.

▸ Build your character

Stop reading. Start leveling.

One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.

  • AI Coach picks 4 missions tailored to your goal
  • Earn XP, build streaks, level up four chapters
  • All evidence-based — no fluff, no upsells
Start your character →Browse missions